glp-1 guidelines for weight loss Rx Trends: Real-World Data on GLP-1s Who Qualifies for Semaglutide GLP-1

Effects of liraglutide in the treatment of obesity: a randomized, double-blind, placebo-controlled study

While gastroparesis caused by medications such as Ozempic is typically reversible, there is some evidence to suggest that it may continue for some time after the drug is discontinued

The mechanism(s) by which GLP-1RAs would cause NAION is also unclear, particularly as GLP-1RAs are associated with neuroprotective properties and reductions in ischemic risk (96), but it has been hypothesized to be related, like the exacerbation of retinopathy, to rapid improvements in glycemic control (Figure 3)

Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al

Of note, GLP-1RAs reduce inflammatory biomarkers like IL-6, CRP, and ferritin in Covid-19 patients